Literature DB >> 11244088

The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor.

M W Wooten1, M L Seibenhener, V Mamidipudi, M T Diaz-Meco, P A Barker, J Moscat.   

Abstract

Nerve growth factor (NGF) binding to both p75 and TrkA neurotrophin receptors activates the transcription factor nuclear factor kappaB (NF-kappaB). Here we show that the atypical protein kinase C-interacting protein, p62, which binds TRAF6, selectively interacts with TrkA but not p75. In contrast, TRAF6 interacts with p75 but not TrkA. We demonstrate the formation of a TRAF6-p62 complex that serves as a bridge linking both p75 and TrkA signaling. Of functional relevance, transfection of antisense p62-enhanced p75-mediated cell death and diminished NGF-induced differentiation occur through a mechanism involving inhibition of IKK activity. These findings reveal a new function for p62 as a common platform for communication of both p75-TRAF6 and TrkA signals. Moreover, we demonstrated that p62 serves as a scaffold for activation of the NF-kappaB pathway, which mediates NGF survival and differentiation responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11244088     DOI: 10.1074/jbc.C000869200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  A Structural View of Negative Regulation of the Toll-like Receptor-Mediated Inflammatory Pathway.

Authors:  Emine Guven-Maiorov; Ozlem Keskin; Attila Gursoy; Ruth Nussinov
Journal:  Biophys J       Date:  2015-08-11       Impact factor: 4.033

2.  D2 dopamine receptor expression and trafficking is regulated through direct interactions with ZIP.

Authors:  Ok-Jin Kim; Marjorie A Ariano; Yoon Namkung; Paul Marinec; Eunmi Kim; Jian Han; David R Sibley
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

3.  The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus.

Authors:  Jeroen J M Hoozemans; Elise S van Haastert; Diana A T Nijholt; Annemieke J M Rozemuller; Piet Eikelenboom; Wiep Scheper
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

Review 4.  Cardiovascular actions of neurotrophins.

Authors:  Andrea Caporali; Costanza Emanueli
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 5.  Atypical protein kinase Cι as a human oncogene and therapeutic target.

Authors:  Peter J Parker; Verline Justilien; Philippe Riou; Mark Linch; Alan P Fields
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

Review 6.  Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.

Authors:  Alan P Fields; Roderick P Regala
Journal:  Pharmacol Res       Date:  2007-05-05       Impact factor: 7.658

Review 7.  P62/SQSTM1 at the interface of aging, autophagy, and disease.

Authors:  Alessandro Bitto; Chad A Lerner; Timothy Nacarelli; Elizabeth Crowe; Claudio Torres; Christian Sell
Journal:  Age (Dordr)       Date:  2014-02-21

8.  The adapter protein ZIP binds Grb14 and regulates its inhibitory action on insulin signaling by recruiting protein kinase Czeta.

Authors:  Bertrand Cariou; Dominique Perdereau; Katia Cailliau; Edith Browaeys-Poly; Véronique Béréziat; Mireille Vasseur-Cognet; Jean Girard; Anne-Françoise Burnol
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

9.  Identification of a consensus site for TRAF6/p62 polyubiquitination.

Authors:  Trafina Jadhav; Thangiah Geetha; Jianxiong Jiang; Marie W Wooten
Journal:  Biochem Biophys Res Commun       Date:  2008-05-05       Impact factor: 3.575

10.  PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-kappaB activation.

Authors:  Kazuhiro Nakamura; Adam J Kimple; David P Siderovski; Gary L Johnson
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.